The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • Gene obtained from curated document aligns with the Allele Registry but not with ClinVar data
  • No CSPEC computed assertion could be determined for this classification!


Variant: NM_000132.3(F8):c.5217C>T (p.Asn1739=)

CA519374734

627324 (ClinVar)

Gene: F8
Condition: hemophilia A
Inheritance Mode: X-linked inheritance
UUID: 5c2a0d18-7d60-4a5d-807c-371e4cd3d281
Approved on: 2024-10-11
Published on: 2025-01-07

HGVS expressions

NM_000132.3:c.5217C>T
NM_000132.3(F8):c.5217C>T (p.Asn1739=)
NC_000023.11:g.154928573G>A
CM000685.2:g.154928573G>A
NC_000023.10:g.154156848G>A
CM000685.1:g.154156848G>A
NC_000023.9:g.153810042G>A
NG_011403.1:g.99151C>T
NG_011403.2:g.99151C>T
ENST00000360256.9:c.5217C>T
ENST00000360256.8:c.5217C>T
NM_000132.4:c.5217C>T
More

Likely Pathogenic

Met criteria codes 3
PM2_Supporting PS4 PP1
Not Met criteria codes 1
PP3

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen Coagulation Factor Deficiency Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for F8 Version 1.0.0

Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
Coagulation Factor Deficiency VCEP
The NM_000132.3(F8):c.5217C>T (p.Asn1739=) synonymous variant is completely absent from population databases (gnomAD v2.1.1/gnomAD v3.1.1). SpliceAI predicts a score of 0.31 for the loss of the canonical donor of intron 14; however the threshold (>0.5) for SpliceAI is not met and does not meet criteria for PP3. At least 4 probands with mild hemophilia A from the literature and internal laboratory data meet F8-phenotype criteria. This variant was found to co-segregate with disease in affected family members, with two meioses observed in a family (Internal Laboratory Data), meeting criteria for PP1. In summary, this variant meets the criteria to be classified as likely pathogenic. ACMG/AMP criteria applied, as specified by the Coagulation Factor Deficiency Variant Curation Expert Panel for F8: PS4, PP1, PM2_Supporting. (ClinGen Coagulation Factor Deficiency Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for F8 Version 1.0.0., Released 10/5/2023).
Met criteria codes
PM2_Supporting
The variant is completely absent from population databases (gnomAD v2.1.1/gnomAD v3)
PS4
4 probands with mild hemophilia A are counted from the literature and internal laboratory data (PMID: 23812942, PMID: 18691168).
PP1
This variant was found to co-segregate with disease in affected family members, with two meioses observed in a family (Internal Laboratory Data), meeting criteria for PP1.
Not Met criteria codes
PP3
The c.5217C>T synonymous variant occurs as the third to last base of exon 14 and the literature indicates that a splicing impact may be predicted. SpliceAI predicts a score of 0.31 for the loss of the canonical donor of intron 14; however the threshold (>0.5) for SpliceAI is not met.
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.